These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27138057)

  • 1. MicroRNAs: how many in inflammatory bowel disease?
    Schaefer JS
    Curr Opin Gastroenterol; 2016 Jul; 32(4):258-66. PubMed ID: 27138057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MiRNAs in Inflammatory Bowel Disease.
    Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
    Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
    de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.
    Soroosh A; Koutsioumpa M; Pothoulakis C; Iliopoulos D
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G256-G262. PubMed ID: 29146677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA in inflammatory bowel disease: Translational research and clinical implication.
    Fisher K; Lin J
    World J Gastroenterol; 2015 Nov; 21(43):12274-82. PubMed ID: 26604636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease.
    Kim HY; Kwon HY; Ha Thi HT; Lee HJ; Kim GI; Hahm KB; Hong S
    J Gastroenterol Hepatol; 2016 Oct; 31(10):1727-1735. PubMed ID: 26878986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in inflammatory bowel disease--pathogenesis, diagnostics and therapeutics.
    Coskun M; Bjerrum JT; Seidelin JB; Nielsen OH
    World J Gastroenterol; 2012 Sep; 18(34):4629-34. PubMed ID: 23002331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
    Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
    James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
    Xu XM; Zhang HJ
    World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNAs and inflammatory bowel disease: An interesting new story.
    Moein S; Vaghari-Tabari M; Qujeq D; Majidinia M; Nabavi SM; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3277-3293. PubMed ID: 30417350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of microRNAs in inflammatory bowel disease.
    Jung H; Kim JS; Lee KH; Tizaoui K; Terrazzino S; Cargnin S; Smith L; Koyanagi A; Jacob L; Li H; Hong SH; Yon DK; Lee SW; Kim MS; Wasuwanich P; Karnsakul W; Shin JI; Kronbichler A
    Int J Biol Sci; 2021; 17(8):2112-2123. PubMed ID: 34131410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease.
    Iborra M; Bernuzzi F; Correale C; Vetrano S; Fiorino G; Beltrán B; Marabita F; Locati M; Spinelli A; Nos P; Invernizzi P; Danese S
    Clin Exp Immunol; 2013 Aug; 173(2):250-8. PubMed ID: 23607522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
    Hübenthal M; Hemmrich-Stanisak G; Degenhardt F; Szymczak S; Du Z; Elsharawy A; Keller A; Schreiber S; Franke A
    PLoS One; 2015; 10(10):e0140155. PubMed ID: 26466382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
    Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
    Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
    Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
    Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response.
    Iborra M; Bernuzzi F; Invernizzi P; Danese S
    Autoimmun Rev; 2012 Mar; 11(5):305-14. PubMed ID: 20627134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
    Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.
    Ghafouri-Fard S; Eghtedarian R; Taheri M
    Biomed Pharmacother; 2020 Sep; 129():110507. PubMed ID: 32768980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.